2'MeO6MF is a brain-penetrant positive allosteric modulator targeting α1-containing and α2β1γ2L GABAA receptors. It demonstrates neuroprotective effects, reduces post-stroke inflammation, and improves functional recovery in vivo, alongside exhibiting anxiolytic and sedative properties in preclinical research.